Development of Oral Medication

1
Development of Oral Medication
Trospium 90-120 mg Tolterodin 4-8 mg
Group 1 n11
Trospium 45 mg
Trospium 90 mg
Oxybutinin 15 mg
Oxybutinin 30 mg
Trospium 90-120 mg Oxybutinin 15-30 mg
Group 2 n8
Tolterodin 4mg
Oxybutinin 15-30 mg Tolterodin 4-8 mg
Tolterodin 8 mg
Group 3 n9
2
Urodynamic Changes
3
Side effects
Four drop out 1 dry mouth,1 vision, 2 lack of
improvement
Dry mouth n6 ? Group 1 1, Group 2 3,
Group 3 2 Vision n1 ?
Group 2 1